Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

60 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 15 8:16 PMDube Eric M
Proposed Sale
64,000$41.09$2.6M—

View →

Apr 15, 2026Apr 15 8:15 PMELIZABETH REED
Proposed Sale
6,785$41.83$283.8K—

View →

Apr 15, 2026Apr 15 8:14 PMCHRISTOPHER CLINE
Proposed Sale
1,014$42.61$43.2K—

View →

Apr 15, 2026Apr 15 8:13 PMJULA INRIG
Proposed Sale
1,018$42.61$43.4K—

View →

Apr 14, 2026Apr 15 1:17 AMElizabeth E. Reed
Proposed Sale
7,215$41.93$302.5K—

View →

Apr 14, 2026Apr 15 12:53 AMJula Inrig
Proposed Sale
7,215$41.93$302.5K—

View →

Apr 14, 2026Apr 15 12:47 AMPeter Heerma
Proposed Sale
7,215$41.93$302.5K—

View →

Apr 14, 2026Apr 15 12:40 AMChristopher Cline
Proposed Sale
7,239$41.93$303.5K—

View →

Apr 14, 2026Apr 14 8:27 PMGARY A LYONS
Proposed Sale
8,000$30.70$245.6K—

View →

Apr 14, 2026Apr 14 8:20 PMCHRISTOPHER CLINE
Proposed Sale
9$41.07$370—

View →

Apr 14, 2026Apr 14 8:19 PMELIZABETH REED
Proposed Sale
37,500$41.07$1.5M—

View →

Apr 14, 2026Apr 14 8:09 PMROY BAYNES
Proposed Sale
32,750$41.29$1.4M—

View →

Apr 14, 2026Apr 14 8:02 PMSANDRA CALVIN
Proposed Sale
21,977$41.07$902.6K—

View →

Apr 13, 2026Apr 14 12:11 AMChristopher Cline
Proposed Sale
65$28.85$1.9K—

View →

Apr 6, 2026Apr 7 10:17 PMRoy D. BaynesDirector
Sale
10,000$33.00$330.0K37,500(D)

View →

Apr 6, 2026Apr 6 8:06 PMROY BAYNES
Proposed Sale
10,000$33.00$330.0K—

View →

Apr 1, 2026Apr 2 9:55 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
60,000$30.93$1.9M432,886(D)

View →

Apr 1, 2026Apr 2 9:55 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$30.00$300.0K105,211(D)

View →

Apr 1, 2026Apr 1 8:13 PMDube Eric M
Proposed Sale
60,000$30.93$1.9M—

View →

Apr 1, 2026Apr 1 8:06 PMELIZABETH REED
Proposed Sale
10,000$30.00$300.0K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 16, 2026Sep 18 1:35 AMWilliam E. RoteChief Research Officer
Option Exercise
112,850$26.880(D)

View →

Sep 15, 2026Sep 18 1:35 AMWilliam E. RoteChief Research Officer
Option Exercise
78,650$25.25350(D)

View →

Sep 17, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
8,282$22.4044,837(D)

View →

Sep 16, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
172,717$26.88500(D)

View →

Sep 15, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
77,190$26.8828,474(D)

View →

Sep 15, 2026Sep 18 1:33 AMJula InrigEVP, Head of R&D & CMO
Option Exercise
32,395$8.9343,605(D)

View →

Sep 15, 2026Sep 18 1:32 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
37,500$15.460(D)

View →

Sep 17, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
108,493$23.340(D)

View →

Sep 16, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
195,841$23.34108,493(D)

View →

Sep 15, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
95,666$23.34304,334(D)

View →

Sep 15, 2026Sep 18 1:30 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Option Exercise
20,000$17.440(D)

View →

Sep 15, 2026Sep 18 1:29 AMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
5,375$27.5017,875(D)

View →

Sep 10, 2026Sep 11 8:05 PMMeckler Jeffrey ADirector
Option Exercise
20,000$26.520(D)

View →

Aug 18, 2026Aug 19 8:05 PMLYONS GARY ADirector
Option Exercise
5,000$17.440(D)

View →

Aug 17, 2026Aug 19 8:05 PMLYONS GARY ADirector
Option Exercise
5,000$17.445,000(D)

View →

Jun 12, 2026Jun 16 8:46 PMTimothy CoughlinDirector
Option Exercise
10,000$26.520(D)

View →

Jun 12, 2026Jun 16 8:42 PMRoy D. BaynesDirector
Option Exercise
4,500$21.380(D)

View →

May 19, 2026May 21 9:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

Page 1 of 4

Next →